Irwin Braverman, MD

• David J Leffell
• Earl Glusac
• Jean Bolognia
• Jordan Pober
• Leonard Milstone
• Lynn D. Wilson
• Marie Robert
• Sydney Spiesel
• William Sessa

Dermatology; Vasculitis

• Pioneers in Dermatology and Venereology: an interview with Prof. Irwin BravermanBraverman I. Pioneers in Dermatology and Venereology: an interview with Prof. Irwin Braverman. Journal Of The European Academy Of Dermatology And Venereology 2019, 33: 2223-2224. PMID: 31779038, DOI: 10.1111/jdv.16040.
• The Dermal Microvascular Unit: Relationship to Immunological Processes and Dermal DendrocytesBraverman I. The Dermal Microvascular Unit: Relationship to Immunological Processes and Dermal Dendrocytes. 2019, 91-115. DOI: 10.1201/9780429261893-6.
• Aaron Bunsen LernerBraverman I. Aaron Bunsen Lerner. 2013, 664-668. DOI: 10.1007/978-3-642-33224-1_111.
• Did Akhenaten Have the Antley–Bixler Syndrome?Braverman I. Did Akhenaten Have the Antley–Bixler Syndrome? Annals Of Internal Medicine 2009, 151: 892. DOI: 10.7326/0003-4819-151-12-200912150-00013.
• Aaron Bunsen Lerner (1920–2007)Braverman I. Aaron Bunsen Lerner (1920–2007). 2008, 620-624. DOI: 10.1007/978-3-540-34093-5_104.
• ArtBraverman I. Art. JAMA 2006, 295: 1840-1845. DOI: 10.1001/jama.295.15.1840.
• Medicine and ArtBraverman I. Medicine and Art. JAMA 2003, 290: 2739-2740. DOI: 10.1001/jama.290.20.2739.
• Cutaneous Complications of Type 1 DiabetesBolognia J, Braverman I. Cutaneous Complications of Type 1 Diabetes. 2003, 0: 485-500. DOI: 10.1385/1-59259-310-0:485.
• The Cutaneous MicrocirculationBraverman I. The Cutaneous Microcirculation. Journal Of Investigative Dermatology Symposium Proceedings 2000, 5: 3-9. PMID: 11147672, DOI: 10.1046/j.1087-0024.2000.00010.x.
• Skin Signs of Systemic DiseaseBraverman I. Skin Signs of Systemic Disease. Journal Of The American Academy Of Dermatology 1999, 40: 786-787. DOI: 10.1016/s0190-9622(99)70171-4.
• Protective effects of erythema nodosum in coccidioidomycosisBraverman I. Protective effects of erythema nodosum in coccidioidomycosis. The Lancet 1999, 353: 168. PMID: 9923870, DOI: 10.1016/s0140-6736(05)77213-5.
• Biliary Tract Obstruction Secondary to Mycosis Fungoides: A Case ReportMadsen J, Tallini G, Glusac E, Salem R, Braverman I, Robert M. Biliary Tract Obstruction Secondary to Mycosis Fungoides: A Case Report. Journal Of Clinical Gastroenterology 1999, 28: 56-60. PMID: 9916670, DOI: 10.1097/00004836-199901000-00015.
• PURPLE (oops! Atrophie blanche) revisited.Milstone L, Braverman I. PURPLE (oops! Atrophie blanche) revisited. JAMA Dermatology 1998, 134: 1634. PMID: 9875208, DOI: 10.1001/archderm.134.12.1634.
• The Cutaneous Microcirculation: Ultrastructure and Microanatomical OrganizationBraverman I. The Cutaneous Microcirculation: Ultrastructure and Microanatomical Organization. Microcirculation 1997, 4: 329-340. PMID: 9329009, DOI: 10.3109/10739689709146797.
• Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)Quirós P, Jones G, Kacinski B, Braverman I, Heald P, Edelson R, Wilson L. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). International Journal Of Radiation Oncology • Biology • Physics 1997, 38: 1027-1035. PMID: 9276369, DOI: 10.1016/s0360-3016(97)00127-2.
• Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphomaWilson L, Quiros P, Kolenik S, Heald P, Braverman I, Edelson R, Kacinski B. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma. Journal Of The American Academy Of Dermatology 1996, 35: 69-73. PMID: 8682967, DOI: 10.1016/s0190-9622(96)90499-5.
• Regional vs Systemic Responses to Mental Stress: A Potential Mechanism for Non-Demand-Related IschemiaSilverman D, Jotkowitz A, Gutter V, Braverman I, O'Connor T. Regional vs Systemic Responses to Mental Stress: A Potential Mechanism for Non-Demand-Related Ischemia. Microvascular Research 1996, 51: 396-399. PMID: 8992237, DOI: 10.1006/mvre.1996.0036.
• 2159 Total skin electron beam therapy(TSEBT) followed by adjuvant psoralen/ultraviolet A light (PUVA) in the management of patients with T1 and T2 cutaneous T-cell lymphoma (CTCL)Quiros P, Kacinski B, Heald P, Edelson R, Braverman I, Wilson L. 2159 Total skin electron beam therapy(TSEBT) followed by adjuvant psoralen/ultraviolet A light (PUVA) in the management of patients with T1 and T2 cutaneous T-cell lymphoma (CTCL). International Journal Of Radiation Oncology • Biology • Physics 1996, 36: 355. DOI: 10.1016/s0360-3016(97)85733-1.
• Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapyWilson L, Licata A, Braverman I, Edelson R, Heald P, Feldman A, Kacinski B. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. International Journal Of Radiation Oncology • Biology • Physics 1995, 32: 987-995. PMID: 7607973, DOI: 10.1016/0360-3016(95)00073-8.
• The Golgi Association of Endothelial Nitric Oxide Synthase Is Necessary for the Efficient Synthesis of Nitric Oxide(∗)Sessa W, Garca-Cardea G, Liu J, Keh A, Pollock J, Bradley J, Thiru S, Braverman I, Desai K. The Golgi Association of Endothelial Nitric Oxide Synthase Is Necessary for the Efficient Synthesis of Nitric Oxide(∗). Journal Of Biological Chemistry 1995, 270: 17641-17644. PMID: 7543089, DOI: 10.1074/jbc.270.30.17641.
• Hypopigmented variant of mycosis fungoides: Demography, histopathology, and treatment of seven casesLambroza E, Cohen S, Phelps R, Lebwohl M, Braverman I, DiCostanzo D. Hypopigmented variant of mycosis fungoides: Demography, histopathology, and treatment of seven cases. Journal Of The American Academy Of Dermatology 1995, 32: 987-993. PMID: 7751470, DOI: 10.1016/0190-9622(95)91337-8.
• Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. JAMA Dermatology 1995, 131: 432-5. PMID: 7726585, DOI: 10.1001/archderm.131.4.432.
• Malignant Melanoma and Other Second Cutaneous Malignancies in Cutaneous T-Cell Lymphoma: The Influence of Additional Therapy After Total Skin Electron Beam RadiationLicata A, Wilson L, Braverman I, Feldman A, Kacinski B. Malignant Melanoma and Other Second Cutaneous Malignancies in Cutaneous T-Cell Lymphoma: The Influence of Additional Therapy After Total Skin Electron Beam Radiation. JAMA Dermatology 1995, 131: 432-435. DOI: 10.1001/archderm.1995.01690160060009.
• Unique and Uncommon Skin Signs of Systemic DiseasesBraverman I. Unique and Uncommon Skin Signs of Systemic Diseases. The Journal Of Dermatology 1994, 21: 929-934. PMID: 7868764, DOI: 10.1111/j.1346-8138.1994.tb03314.x.
• Inducibility and Expression of Microvascular Endothelial Adhesion Molecules in Lesional, Perilesional, and Uninvolved Skin of Psoriatic PatientsPetzelbauer P, Pober J, Keh A, Braverman I. Inducibility and Expression of Microvascular Endothelial Adhesion Molecules in Lesional, Perilesional, and Uninvolved Skin of Psoriatic Patients. Journal Of Investigative Dermatology 1994, 103: 300-305. PMID: 7521374, DOI: 10.1111/1523-1747.ep12394720.
• Spatial Heterogeneity in Normal Skin Perfusion Recorded with Laser Doppler Imaging and FlowmetryWardell K, Braverman I, Silverman D, Nilsson G. Spatial Heterogeneity in Normal Skin Perfusion Recorded with Laser Doppler Imaging and Flowmetry. Microvascular Research 1994, 48: 26-38. PMID: 7990721, DOI: 10.1006/mvre.1994.1036.
• Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapyWilson L, Cooper D, Goodrich A, Friedman N, Feldman A, Braverman I, Kacinski B. Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. International Journal Of Radiation Oncology • Biology • Physics 1994, 28: 829-837. PMID: 8138435, DOI: 10.1016/0360-3016(94)90102-3.
• Localization and abundance of fodrin during keratinocyte differentiationYounes M, Paus R, Stenn K, Braverman I, Keh-Yen A. Localization and abundance of fodrin during keratinocyte differentiation. In Vitro Cellular & Developmental Biology - Animal 1994, 30: 69-74. PMID: 8012656, DOI: 10.1007/bf02631393.
• The utility of adjuvant psoralen + ultraviolet-a light [PUVA] therapy in maintaining cutaneous remission in T1 and T2 CTCL (mycosis fungoides) treated with total skin electron beam radiation therapy [TSEBT]Kolenli S, Kacinski B, Quiros P, Wilson L, Heald P, Edelson R, Braverman I. The utility of adjuvant psoralen + ultraviolet-a light [PUVA] therapy in maintaining cutaneous remission in T1 and T2 CTCL (mycosis fungoides) treated with total skin electron beam radiation therapy [TSEBT]. International Journal Of Radiation Oncology • Biology • Physics 1994, 30: 266. DOI: 10.1016/0360-3016(94)90820-6.
• Novel prognostic factors predictive of prolonged relapse-free and overall survival in advanced stage CTCL (mycosis fungoides) patients treated with total skin electron beam therapyKacinski B, Wilson L, Quiros P, Kolenik S, Heald P, Edelson R, Braverman I. Novel prognostic factors predictive of prolonged relapse-free and overall survival in advanced stage CTCL (mycosis fungoides) patients treated with total skin electron beam therapy. International Journal Of Radiation Oncology • Biology • Physics 1994, 30: 268. DOI: 10.1016/0360-3016(94)90823-0.
• Additional courses of total skin electron beam therapy [TSEBT] in the retreatment of patients with cutaneous t-cell lymphoma [CTCL]Wilson L, Quiros P, Kolenik S, Heald P, Braverman I, Edelson R, Kacinski B. Additional courses of total skin electron beam therapy [TSEBT] in the retreatment of patients with cutaneous t-cell lymphoma [CTCL]. International Journal Of Radiation Oncology • Biology • Physics 1994, 30: 269. DOI: 10.1016/0360-3016(94)90825-7.
• Dermatosparaxis in Children: A Case Report and Review of the Newly Recognized PhenotypePetty E, Seashore M, Braverman I, Spiesel S, Smith L, Milstone L. Dermatosparaxis in Children: A Case Report and Review of the Newly Recognized Phenotype. JAMA Dermatology 1993, 129: 1310-1315. DOI: 10.1001/archderm.1993.01680310080014.
• Transformation in Cutaneous T-Cell LymphomaBraverman I, Redfern C. Transformation in Cutaneous T-Cell Lymphoma. Journal Of Investigative Dermatology 1993, 101: 249-251. PMID: 8370959, DOI: 10.1111/1523-1747.ep12365124.
• Cyclosporine treatment of refractory T‐cell lymphomasCooper D, Braverman I, Sarris A, Durivage H, Saidman B, Davis C, Hait W. Cyclosporine treatment of refractory T‐cell lymphomas. Cancer 1993, 71: 2335-2341. PMID: 8453556, DOI: 10.1002/1097-0142(19930401)71:7<2335::aid-cncr2820710727>3.0.co;2-d.
• Adjuvant Extracorporeal Photoimmunotherapy or adjuvant adriamyciwcytoxan chemotherapy both prolong survival for cutaneous T-cell lymphoma (CTCL, MYCOSIS FUNGOIDES) patients treated with total skin electron beam therapy (TSEBT).Kacinaki B, Wilson L, Goodrich A, Edelson R, Heald P, Braverman I. Adjuvant Extracorporeal Photoimmunotherapy or adjuvant adriamyciwcytoxan chemotherapy both prolong survival for cutaneous T-cell lymphoma (CTCL, MYCOSIS FUNGOIDES) patients treated with total skin electron beam therapy (TSEBT). International Journal Of Radiation Oncology • Biology • Physics 1993, 27: 186-187. DOI: 10.1016/0360-3016(93)90727-d.
• Increased incidence of malignant melanoma and other second cutaneous malignancies after total skin electron beam therapy (TSEBT) for CTCL (mycosis fungoldes)Goodrich A, Wilson L, Braverman I, Kacinski B. Increased incidence of malignant melanoma and other second cutaneous malignancies after total skin electron beam therapy (TSEBT) for CTCL (mycosis fungoldes). International Journal Of Radiation Oncology • Biology • Physics 1993, 27: 187. DOI: 10.1016/0360-3016(93)90728-e.
• Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.Smith L, Wertelecki W, Milstone L, Petty E, Seashore M, Braverman I, Jenkins T, Byers P. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen. American Journal Of Human Genetics 1992, 51: 235-44. PMID: 1642226, PMCID: PMC1682688.
• Synchronous vasomotion in the human cutaneous microvasculature provides evidence for central modulationSchechner J, Braverman I. Synchronous vasomotion in the human cutaneous microvasculature provides evidence for central modulation. Microvascular Research 1992, 44: 27-32. PMID: 1640877, DOI: 10.1016/0026-2862(92)90099-b.
• Topographic mapping of the cutaneous microcirculation using two outputs of laser-Doppler flowmetry: Flux and the concentration of moving blood cellsBraverman I, Schechner J, Silverman D, Keh-Yen A. Topographic mapping of the cutaneous microcirculation using two outputs of laser-Doppler flowmetry: Flux and the concentration of moving blood cells. Microvascular Research 1992, 44: 33-48. PMID: 1640878, DOI: 10.1016/0026-2862(92)90100-4.
• Pseudoxanthoma-elasticum-Like Skin Changes Induced by PenicillamineBolognia J, Braverman I. Pseudoxanthoma-elasticum-Like Skin Changes Induced by Penicillamine. Dermatology 1992, 184: 12-18. PMID: 1558988, DOI: 10.1159/000247491.
• The role of novel prognostic factors & adjuvant therapy in CTCL (Mycosis fungoides) patients treated with total skin electron beam therapyKacinski B, Murren J, Friedman N, Braverman I, Cooper D. The role of novel prognostic factors & adjuvant therapy in CTCL (Mycosis fungoides) patients treated with total skin electron beam therapy. International Journal Of Radiation Oncology • Biology • Physics 1992, 24: 229. DOI: 10.1016/0360-3016(92)90308-5.
• Contour Mapping of the Cutaneous Microvasculature by Computerized Laser Doppler VelocimetryBraverman I, Schechner J. Contour Mapping of the Cutaneous Microvasculature by Computerized Laser Doppler Velocimetry. Journal Of Investigative Dermatology 1991, 97: 1013-1018. PMID: 1748811, DOI: 10.1111/1523-1747.ep12492255.
• Cutaneous T-cell lymphomaBraverman I. Cutaneous T-cell lymphoma. Current Problems In Dermatology 1991, 3: 184-227. DOI: 10.1016/1040-0486(91)90005-o.
• The Use of Immunohistologic Analysis in Differentiating Cutaneous T-cell Lymphoma From Psoriasis and DermatitisVerga M, Braverman I. The Use of Immunohistologic Analysis in Differentiating Cutaneous T-cell Lymphoma From Psoriasis and Dermatitis. JAMA Dermatology 1991, 127: 1503-1510. PMID: 1929457, DOI: 10.1001/archderm.1991.01680090067006.
• Bowen's Disease and Internal CancerBraverman I. Bowen's Disease and Internal Cancer. JAMA 1991, 266: 842-843. PMID: 1883414, DOI: 10.1001/jama.1991.03470060104037.
• Repeat courses of either total skin electron beam therapy (TSEBT) or local RT are safe and effective palliation to relapsed CTCL patients whose symptoms are not controlled by other topical or systemic anti-ctcl therapiesKacinski B, Friedrtan N, Murren J, Cooper D, Braverman I. Repeat courses of either total skin electron beam therapy (TSEBT) or local RT are safe and effective palliation to relapsed CTCL patients whose symptoms are not controlled by other topical or systemic anti-ctcl therapies. International Journal Of Radiation Oncology • Biology • Physics 1991, 21: 212. DOI: 10.1016/0360-3016(91)90608-7.
• Ultrastructure and Three-Dimensional Organization of the Telangiectases of Hereditary Hemorrhagic TelangiectasiaBraverman I, Keh A, Jacobson B. Ultrastructure and Three-Dimensional Organization of the Telangiectases of Hereditary Hemorrhagic Telangiectasia. Journal Of Investigative Dermatology 1990, 95: 422-427. PMID: 2212727, DOI: 10.1111/1523-1747.ep12555569.
• Correlation of Laser Doppler Wave Patterns with Underlying Microvascular AnatomyBraverman I, Keh A, Goldminz D. Correlation of Laser Doppler Wave Patterns with Underlying Microvascular Anatomy. Journal Of Investigative Dermatology 1990, 95: 283-286. PMID: 2143522, DOI: 10.1111/1523-1747.ep12484917.
• Ultrastructural Analysis of the Endothelial-Pericyte Relationship in Diabetic Cutaneous VesselsBraverman I, Sibley J, Keh A. Ultrastructural Analysis of the Endothelial-Pericyte Relationship in Diabetic Cutaneous Vessels. Journal Of Investigative Dermatology 1990, 95: 147-153. PMID: 2380575, DOI: 10.1111/1523-1747.ep12477903.
• Ultrastructural and Three-Dimensional Analysis of the Contractile Cells of the Cutaneous MicrovasculatureBraverman I, Sibley J. Ultrastructural and Three-Dimensional Analysis of the Contractile Cells of the Cutaneous Microvasculature. Journal Of Investigative Dermatology 1990, 95: 90-96. PMID: 2366005, DOI: 10.1111/1523-1747.ep12874034.
• Skin changes in menopauseBolognia J, Braverman I, Rousseau M, Sarrel P. Skin changes in menopause. Maturitas 1989, 11: 295-304. PMID: 2693917, DOI: 10.1016/0378-5122(89)90026-1.
• Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis.Malhotra R, Stenn K, Fernandez L, Braverman I. Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Laboratory Investigation 1989, 61: 162-5. PMID: 2474089.
• Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states.Braverman I. Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. Journal Of Investigative Dermatology 1989, 93: 2s-9s. PMID: 2666519, DOI: 10.1111/1523-1747.ep12580893.
• Ultrastructure and Organization of the Cutaneous Microvasculature in Normal and Pathologic StatesBraverman I. Ultrastructure and Organization of the Cutaneous Microvasculature in Normal and Pathologic States. Journal Of Investigative Dermatology 1989, 93: s2-s9. DOI: 10.1038/jid.1989.2.
• A hypothetical explanation for the aging of skin. Chronologic alteration of the three-dimensional arrangement of collagen and elastic fibers in connective tissue.Imayama S, Braverman I. A hypothetical explanation for the aging of skin. Chronologic alteration of the three-dimensional arrangement of collagen and elastic fibers in connective tissue. American Journal Of Pathology 1989, 134: 1019-25. PMID: 2719072, PMCID: PMC1879910.
• Elastic Fiber and Microvascular Abnormalities in Aging SkinBraverman I. Elastic Fiber and Microvascular Abnormalities in Aging Skin. Clinics In Geriatric Medicine 1989, 5: 69-90. PMID: 2646003, DOI: 10.1016/s0749-0690(18)30696-7.
• Sustained complete remission of skin disease in advanced CTCLFrank A, Kacinski B, Schwartz J, McKiernan G, Edelson R, Braverman I, Heald P, Hait W. Sustained complete remission of skin disease in advanced CTCL. International Journal Of Radiation Oncology • Biology • Physics 1989, 17: 226. DOI: 10.1016/0360-3016(89)90839-0.
• Scanning electron microscope study of elastic fibers of the loose connective tissue (superficial fascia) in the ratImayama S, Braverman I. Scanning electron microscope study of elastic fibers of the loose connective tissue (superficial fascia) in the rat. The Anatomical Record 1988, 222: 115-120. PMID: 3213961, DOI: 10.1002/ar.1092220202.
• Computers and MorphologyBraverman I. Computers and Morphology. JAMA Dermatology 1988, 124: 1415-1417. PMID: 3415287, DOI: 10.1001/archderm.1988.01670090071016.
• Age of onset, pattern of distribution, and histology of aneurysm development in a genetically predisposed mouse modelBrophy C, Tilson J, Braverman I, Tilson M. Age of onset, pattern of distribution, and histology of aneurysm development in a genetically predisposed mouse model. Journal Of Vascular Surgery 1988, 8: 45-48. DOI: 10.1067/mva.1988.avs0080045.
• Age of onset, pattern of distribution, and histology of aneurysm development in a genetically predisposed mouse modelBrophy C, Tilson J, Braverman I, Tilson M. Age of onset, pattern of distribution, and histology of aneurysm development in a genetically predisposed mouse model. Journal Of Vascular Surgery 1988, 8: 45-48. PMID: 3385878, DOI: 10.1016/0741-5214(88)90242-x.
• Progression of pigmented purpura-like eruptions to mycosis fungoides: Report of three casesBarnhill R, Braverman I. Progression of pigmented purpura-like eruptions to mycosis fungoides: Report of three cases. Journal Of The American Academy Of Dermatology 1988, 19: 25-31. PMID: 3403742, DOI: 10.1016/s0190-9622(88)70147-4.
• Combined total body electron beam irradiation and chemotherapy for mycosis fungoidesBraverman I, Yager N, Chen M, Cadman E, Hait W, Maynard T. Combined total body electron beam irradiation and chemotherapy for mycosis fungoides. Journal Of The American Academy Of Dermatology 1987, 16: 45-60. PMID: 3100583, DOI: 10.1016/s0190-9622(87)70004-8.
• Electron microscopic and immunolabeling studies of the lesional and normal skin of patients with mycosis fungoides treated by total body electron beam irradiationBraverman I, Klein S, Grant A. Electron microscopic and immunolabeling studies of the lesional and normal skin of patients with mycosis fungoides treated by total body electron beam irradiation. Journal Of The American Academy Of Dermatology 1987, 16: 61-74. PMID: 3100584, DOI: 10.1016/s0190-9622(87)70005-x.
• Dermatology in primary care: A problem-oriented guide Stanford I. Larnberg, M.D., Philadelphia, 1986, W. B. Saunders Co. 411 pages. $24.95.Braverman I. Dermatology in primary care: A problem-oriented guide Stanford I. Larnberg, M.D., Philadelphia, 1986, W. B. Saunders Co. 411 pages. $24.95. Journal Of The American Academy Of Dermatology 1987, 16: 164-165. DOI: 10.1016/s0190-9622(87)80200-1.
• Whole skin electron beam radiotherapy and adjuvant chemotherapy for mycosis fungoidesChen M, Braverman I, Haiti W, Cadman E. Whole skin electron beam radiotherapy and adjuvant chemotherapy for mycosis fungoides. International Journal Of Radiation Oncology • Biology • Physics 1986, 12: 160. DOI: 10.1016/0360-3016(86)90635-8.
• Familial multiple lipomatosis Report of a case and a review of the literatureLeffell D, Braverman I. Familial multiple lipomatosis Report of a case and a review of the literature. Journal Of The American Academy Of Dermatology 1986, 15: 275-279. PMID: 3745530, DOI: 10.1016/s0190-9622(86)70166-7.
• Elastic Fiber and Microvascular Abnormalities in Aging SkinBraverman I. Elastic Fiber and Microvascular Abnormalities in Aging Skin. Dermatologic Clinics 1986, 4: 391-405. PMID: 3521985, DOI: 10.1016/s0733-8635(18)30802-7.
• Three-Dimensional Reconstruction of Endothelial Cell Gaps in Psoriatic Vessels and Their Morphologic Identity with Gaps Produced by the Intradermal Injections of HistamineBraverman I, Keh-Yen A. Three-Dimensional Reconstruction of Endothelial Cell Gaps in Psoriatic Vessels and Their Morphologic Identity with Gaps Produced by the Intradermal Injections of Histamine. Journal Of Investigative Dermatology 1986, 86: 577-581. PMID: 3745967, DOI: 10.1111/1523-1747.ep12355222.
• Three-Dimensional Reconstructions of Objects from Serial Sections Using a Microcomputer Graphics SystemBraverman M, Braverman I. Three-Dimensional Reconstructions of Objects from Serial Sections Using a Microcomputer Graphics System. Journal Of Investigative Dermatology 1986, 86: 290-294. PMID: 3745954, DOI: 10.1111/1523-1747.ep12285445.
• A Study of the Veil Cells Around Normal, Diabetic, and Aged Cutaneous MicrovesselsBraverman I, Sibley J, Keh-Yen A. A Study of the Veil Cells Around Normal, Diabetic, and Aged Cutaneous Microvessels. Journal Of Investigative Dermatology 1986, 86: 57-62. PMID: 3745935, DOI: 10.1111/1523-1747.ep12283816.
• The Response of Psoriatic Epidermis and Microvessels to Treatment with Topical Steroids and Oral MethotrexateBraverman I, Sibley J. The Response of Psoriatic Epidermis and Microvessels to Treatment with Topical Steroids and Oral Methotrexate. Journal Of Investigative Dermatology 1985, 85: 584-586. PMID: 4067330, DOI: 10.1111/1523-1747.ep12283604.
• Ultrastructural Abnormalities of the Microvasculature and Elastic Fibers in the Skin of Juvenile DiabeticsBraverman I, Keh-Yen A. Ultrastructural Abnormalities of the Microvasculature and Elastic Fibers in the Skin of Juvenile Diabetics. Journal Of Investigative Dermatology 1984, 82: 270-274. PMID: 6699427, DOI: 10.1111/1523-1747.ep12260279.
• Classification and Therapy of Atrophie BlancheMilstone L, Braverman I, Lucky P, Fleckman P. Classification and Therapy of Atrophie Blanche. JAMA Dermatology 1983, 119: 963-969. PMID: 6651312, DOI: 10.1001/archderm.1983.01650360009005.
• Ultrastructure and Three-Dimensional Reconstruction of Several Macular and Papular TelangiectasesBraverman I, Keh-Yen A. Ultrastructure and Three-Dimensional Reconstruction of Several Macular and Papular Telangiectases. Journal Of Investigative Dermatology 1983, 81: 489-497. PMID: 6417247, DOI: 10.1111/1523-1747.ep12522736.
• Ultrastructure of the Human Dermal Microcirculation. IV. Valve-Containing Collecting Veins at the Dermal–Subcutaneous JunctionBraverman I, Keh-Yen A. Ultrastructure of the Human Dermal Microcirculation. IV. Valve-Containing Collecting Veins at the Dermal–Subcutaneous Junction. Journal Of Investigative Dermatology 1983, 81: 438-442. PMID: 6631054, DOI: 10.1111/1523-1747.ep12522612.
• The role of blood vessels and lymphatics in cutaneous inflammatory processes: an overview.Braverman I. The role of blood vessels and lymphatics in cutaneous inflammatory processes: an overview. British Journal Of Dermatology 1983, 109 Suppl 25: 89-98. PMID: 6344912.
• Commentary: Migratory Necrolytic ErythemaBraverman I. Commentary: Migratory Necrolytic Erythema. JAMA Dermatology 1982, 118: 796-798. DOI: 10.1001/archderm.1982.01650220100012.
• Studies in Cutaneous Aging: I. The Elastic Fiber NetworkBraverman I, Fonferko E. Studies in Cutaneous Aging: I. The Elastic Fiber Network. Journal Of Investigative Dermatology 1982, 78: 434-443. PMID: 7069221, DOI: 10.1111/1523-1747.ep12507866.
• Studies in Cutaneous Aging II. The MicrovasculatureBraverman I, Fonferko E. Studies in Cutaneous Aging II. The Microvasculature. Journal Of Investigative Dermatology 1982, 78: 444-448. PMID: 7069222, DOI: 10.1111/1523-1747.ep12508027.
• Role of the Microcirculation in the Treatment and Pathogenesis of PsoriasisBraverman I, Sibley J. Role of the Microcirculation in the Treatment and Pathogenesis of Psoriasis. Journal Of Investigative Dermatology 1982, 78: 12-17. PMID: 7054305, DOI: 10.1111/1523-1747.ep12497850.
• Ultrastructure of the Human Dermal Microcirculation. III. The Vessels in the Mid- and Lower Dermis and Subcutaneous FatBraverman I, Keh-Yen A. Ultrastructure of the Human Dermal Microcirculation. III. The Vessels in the Mid- and Lower Dermis and Subcutaneous Fat. Journal Of Investigative Dermatology 1981, 77: 297-304. PMID: 7264363, DOI: 10.1111/1523-1747.ep12482470.
• DermatologyBraverman I. Dermatology. Postgraduate Medicine 1981, 69: 130-131. DOI: 10.1080/00325481.1981.11715761.
• An unusual and fatal case of disseminated cutaneous herpes simplex Infection in a patient with cutaneous T cell lymphoma (mycosis fungoides)Goldgeier M, Cohen S, Braverman I, Stenn K. An unusual and fatal case of disseminated cutaneous herpes simplex Infection in a patient with cutaneous T cell lymphoma (mycosis fungoides). Journal Of The American Academy Of Dermatology 1981, 4: 176-180. PMID: 7217388, DOI: 10.1016/s0190-9622(81)70021-5.
• Cisplatin treatment of cutaneous T-cell lymphoma.Witman G, Cadman E, Braverman I. Cisplatin treatment of cutaneous T-cell lymphoma. Journal Of The National Cancer Institute 1981, 65: 920. PMID: 6974043.
• Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factorCohen S, Stenn K, Braverman I, Beck G. Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 1980, 46: 2654-2666. PMID: 6778603, DOI: 10.1002/1097-0142(19801215)46:12<2654::aid-cncr2820461220>3.0.co;2-1.
• Necrolytic Migratory Erythema Without Glucagonoma: Report of Two CasesGoodenberger D, Lawley T, Strober W, Wyatt L, Sangree M, Sherwin R, Rosenbaum H, Braverman I, Katz S. Necrolytic Migratory Erythema Without Glucagonoma: Report of Two Cases. JAMA Dermatology 1979, 115: 1429-1432. PMID: 533289, DOI: 10.1001/archderm.1979.04010120027012.
• Striped nails and kidney transplantation.BRAVERMAN I. Striped nails and kidney transplantation. Annals Of Internal Medicine 1978, 89: 286-7. PMID: 354453, DOI: 10.7326/0003-4819-89-2-286.
• Psoriasis (A Brief Course in Dermatology)Braverman I. Psoriasis (A Brief Course in Dermatology). Journal Of Investigative Dermatology 1977, 68: 115. DOI: 10.1111/1523-1747.ep12491845.
• ULTRASTRUCTURE OF THE CAPILLARY LOOPS IN THE DERMAL PAPILLAE OF PSORIASISBraverman I, Yen A. ULTRASTRUCTURE OF THE CAPILLARY LOOPS IN THE DERMAL PAPILLAE OF PSORIASIS. Journal Of Investigative Dermatology 1977, 68: 53-60. PMID: 830771, DOI: 10.1111/1523-1747.ep12485169.
• ULTRASTRUCTURE OF THE HUMAN DERMAL MICROCIRCULATIONBraverman I, Yen A. ULTRASTRUCTURE OF THE HUMAN DERMAL MICROCIRCULATION. Journal Of Investigative Dermatology 1977, 68: 44-52. PMID: 830769, DOI: 10.1111/1523-1747.ep12485165.
• SKIN SIGNS OF SYSTEMIC DISEASEBraverman I, Saunders W, ROBINSON D. SKIN SIGNS OF SYSTEMIC DISEASE. Plastic & Reconstructive Surgery 1976, 57: 657. DOI: 10.1097/00006534-197605000-00016.
• Ultrastructure Of The Human Dermal Microcirculation: The Horizontal Plexus Of The Papillary DermisYen A, Braverman I. Ultrastructure Of The Human Dermal Microcirculation: The Horizontal Plexus Of The Papillary Dermis. Journal Of Investigative Dermatology 1976, 66: 131-142. PMID: 1249441, DOI: 10.1111/1523-1747.ep12481678.
• Urticaria (Book) Robert P. Wario Robert H. Champion Volume I in the Series, Major Problems in Dermatology, Arthur Rook, M.D., F.R.C.P., Consulting Editor 1974 W. B. Saunders Company Philadelphia 173 $13.50Braverman I. Urticaria (Book) Robert P. Wario Robert H. Champion Volume I in the Series, Major Problems in Dermatology, Arthur Rook, M.D., F.R.C.P., Consulting Editor 1974 W. B. Saunders Company Philadelphia 173 $13.50. Journal Of Investigative Dermatology 1975, 64: 196-197. DOI: 10.1111/1523-1747.ep12533362.
• Demonstration of Immune Complexes in Spontaneous and Histamine-Induced Lesions and in Normal Skin of Patients with Leukocytoclastic AngiitisBraverman I, Yen A. Demonstration of Immune Complexes in Spontaneous and Histamine-Induced Lesions and in Normal Skin of Patients with Leukocytoclastic Angiitis. Journal Of Investigative Dermatology 1975, 64: 105-112. PMID: 123546, DOI: 10.1111/1523-1747.ep12510321.
• Microcirculation in Psoriatic SkinBraverman I, Yen A. Microcirculation in Psoriatic Skin. Journal Of Investigative Dermatology 1974, 62: 493-502. PMID: 4823589, DOI: 10.1111/1523-1747.ep12681007.
• Annulus Migrans: Identical Lesions in Pustular Psoriasis, Reiter's Syndrome, and Geographic TongueO'Keefe E, Braverman I, Cohen I. Annulus Migrans: Identical Lesions in Pustular Psoriasis, Reiter's Syndrome, and Geographic Tongue. JAMA Dermatology 1973, 107: 240-244. DOI: 10.1001/archderm.1973.01620170052014.
• The Multiple Lentigines SyndromeNordlund J, Lerner A, Braverman I, McGuire J. The Multiple Lentigines Syndrome. JAMA Dermatology 1973, 107: 259-261. PMID: 4685582, DOI: 10.1001/archderm.1973.01620170067018.
• Electron Microscopic Studies of the Microcirculation in PsoriasisBraverman I. Electron Microscopic Studies of the Microcirculation in Psoriasis. Journal Of Investigative Dermatology 1972, 59: 91-98. PMID: 5039967, DOI: 10.1111/1523-1747.ep12625852.
• Metabolic and Ultrastructural Studies in a Patient With Pustular Psoriasis (von Zumbusch)Braverman I, Cohen I, O'Keefe E. Metabolic and Ultrastructural Studies in a Patient With Pustular Psoriasis (von Zumbusch). JAMA Dermatology 1972, 105: 189-196. PMID: 4334267, DOI: 10.1001/archderm.1972.01620050003001.
• Cutaneous Manifestations of Diabetes MellitusBraverman I. Cutaneous Manifestations of Diabetes Mellitus. Medical Clinics Of North America 1971, 55: 1019-1029. PMID: 4946754, DOI: 10.1016/s0025-7125(16)32495-6.
• Skin Signs of Systemic DiseaseBraverman I. Skin Signs of Systemic Disease. Southern Medical Journal 1971, 64: 642. DOI: 10.1097/00007611-197105000-00039.
• Study of Autoimmune Disease in New Zealand Mice. IV. Immunologic Reactivity and Reticuloendothelial Function* * From the Section of Dermatology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.Braverman I, Slesinski J. Study of Autoimmune Disease in New Zealand Mice. IV. Immunologic Reactivity and Reticuloendothelial Function* * From the Section of Dermatology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06510. Journal Of Investigative Dermatology 1970, 55: 317-324. PMID: 4098509, DOI: 10.1111/1523-1747.ep12260187.
• White spots in tuberous sclerosisHurwitz S, Braverman I. White spots in tuberous sclerosis. The Journal Of Pediatrics 1970, 77: 587-594. PMID: 5454707, DOI: 10.1016/s0022-3476(70)80199-8.
• Vistas in Connective Tissue DiseasesBraverman I. Vistas in Connective Tissue Diseases. The Yale Journal Of Biology And Medicine 1969, 41: 409-410. PMCID: PMC2591477.
• Opinions of Those in Training 1968Braverman I. Opinions of Those in Training 1968. JAMA Dermatology 1969, 99: 304-311. DOI: 10.1001/archderm.1969.01610210058013.
• Study of Autoimmune Disease in New Zealand Mice III. Mechanisms Underlying Hemolytic Anemia of NZB Mice* * From the Section of Dermatology, Department of Medicine, Yale University School of Medicine, New Haven, Conn.Braverman I, Slesinski J. Study of Autoimmune Disease in New Zealand Mice III. Mechanisms Underlying Hemolytic Anemia of NZB Mice* * From the Section of Dermatology, Department of Medicine, Yale University School of Medicine, New Haven, Conn. Journal Of Investigative Dermatology 1968, 51: 274-279. PMID: 4877762, DOI: 10.1038/jid.1968.127.
• Study of Autoimmune Disease in New Zealand Mice I. Genetic Features and Natural History of NZB, NZY and NZW Strains and NZB/NZW Hybrids* * From the Section of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510.Braverman I. Study of Autoimmune Disease in New Zealand Mice I. Genetic Features and Natural History of NZB, NZY and NZW Strains and NZB/NZW Hybrids* * From the Section of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510. Journal Of Investigative Dermatology 1968, 50: 483-499. PMID: 4172399, DOI: 10.1038/jid.1968.79.
• Esophageal Manometry in SclerodermaKaufmann H, Braverman I, Spiro H. Esophageal Manometry in Scleroderma. Scandinavian Journal Of Gastroenterology 1968, 3: 246-254. PMID: 5708099, DOI: 10.3109/00365526809180597.
• Study of Autoimmune Disease in New Zealand Mice II. Immunologic and Parabiotic Studies of NZB/NZW F1 Hybrids*Braverman I. Study of Autoimmune Disease in New Zealand Mice II. Immunologic and Parabiotic Studies of NZB/NZW F1 Hybrids*. Journal Of Investigative Dermatology 1967, 49: 469-473. PMID: 4169041, DOI: 10.1038/jid.1967.167.
• Urticaria as a Sign of Internal DiseaseBraverman I. Urticaria as a Sign of Internal Disease. Postgraduate Medicine 1967, 41: 450-454. PMID: 6044098, DOI: 10.1080/00325481.1967.11696947.
• Progress in the Biological Sciences in Relation to Dermatology-2Braverman I. Progress in the Biological Sciences in Relation to Dermatology-2. The Yale Journal Of Biology And Medicine 1965, 37: 542-543. PMCID: PMC2604748.
• Zirconium: Its Effect on the Reticuloendothelial System and Action as an Immunologic Adjuvant* * From the Department of Medicine, Section of Dermatology, Yale University School of Medicine, New Haven, Connecticut.Braverman I, Marino J. Zirconium: Its Effect on the Reticuloendothelial System and Action as an Immunologic Adjuvant* * From the Department of Medicine, Section of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Journal Of Investigative Dermatology 1964, 43: 509-518. PMID: 14234857, DOI: 10.1038/jid.1964.193.
• Dilantin-induced serum sickness Case report and inquiry into its mechanismBraverman I, Levin J. Dilantin-induced serum sickness Case report and inquiry into its mechanism. The American Journal Of Medicine 1963, 35: 418-422. PMID: 14065882, DOI: 10.1016/0002-9343(63)90184-0.
• Hydralazine Disease in the Guinea-pig as an Experimental Model for Lupus ErythematosusBraverman I, Lerner A. Hydralazine Disease in the Guinea-pig as an Experimental Model for Lupus Erythematosus. Journal Of Investigative Dermatology 1962, 39: 317-327. PMID: 14015095, DOI: 10.1038/jid.1962.119.
• Psoriasis, Lupus Erythematosus, and Pityriasis Rubra Pilaris: Occurrence in One FamilyLERNER M, BRAVERMAN I. Psoriasis, Lupus Erythematosus, and Pityriasis Rubra Pilaris: Occurrence in One Family. JAMA Dermatology 1962, 85: 229-231. PMID: 14464250, DOI: 10.1001/archderm.1962.01590020069008.
• Diffuse Malignant Proliferation of Vascular Endothelium: A Possible New Clinical and Pathological EntityBRAVERMAN I, LERNER A. Diffuse Malignant Proliferation of Vascular Endothelium: A Possible New Clinical and Pathological Entity. JAMA Dermatology 1961, 84: 22-30. DOI: 10.1001/archderm.1961.01580130028004.
• Neurological actions caused by the mutant gene Trembler in the house mouse (Mus musculus, L.,) an investigation.Braverman I. Neurological actions caused by the mutant gene Trembler in the house mouse (Mus musculus, L.,) an investigation. Journal Of Neuropathology & Experimental Neurology 1953, 12: 64-72. PMID: 13000456, DOI: 10.1097/00005072-195301000-00006.